HSBC Holdings’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $71.3K | Sell |
20,093
-251
| -1% | -$891 | ﹤0.01% | 2425 |
|
|
2025
Q1 | $45K | Sell |
20,344
-1,155
| -5% | -$2.55K | ﹤0.01% | 2461 |
|
|
2024
Q4 | $62.5K | Buy |
21,499
+2
| +0% | +$6 | ﹤0.01% | 2528 |
|
|
2024
Q3 | $56.4K | Hold |
21,497
| – | – | ﹤0.01% | 2485 |
|
|
2024
Q2 | $63.4K | Sell |
21,497
-68,403
| -76% | -$202K | ﹤0.01% | 2425 |
|
|
2024
Q1 | $407K | Sell |
89,900
-424
| -0.5% | -$1.92K | ﹤0.01% | 1823 |
|
|
2023
Q4 | $513K | Buy |
90,324
+56,526
| +167% | +$321K | ﹤0.01% | 1622 |
|
|
2023
Q3 | $155K | Buy |
33,798
+19,274
| +133% | +$88.6K | ﹤0.01% | 1983 |
|
|
2023
Q2 | $93.9K | Buy |
+14,524
| New | +$93.9K | ﹤0.01% | 1999 |
|
|
2022
Q4 | – | Sell |
-79,799
| Closed | -$797K | – | 2545 |
|
|
2022
Q3 | $797K | Buy |
79,799
+19,492
| +32% | +$195K | ﹤0.01% | 1554 |
|
|
2022
Q2 | $650K | Buy |
+60,307
| New | +$650K | ﹤0.01% | 1803 |
|